Bleeding in a patient receiving platelet aggregation inhibitors

Anesthesia and Analgesia

Volumn 93, Issue 4, 2001, Pages 878-882

  Waters, Jonathan H ^a   Anthony, David G ^a   Gottlieb, Alexandru ^a   Sprung, Juraj ^b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; EPTIFIBATIDE; FIBRINOGEN RECEPTOR ANTAGONIST;

ABDOMINAL AORTA ANEURYSM; AGED; ARTICLE; BLEEDING; BLOOD CLOT RETRACTION; CAROTID ARTERY OBSTRUCTION; CASE REPORT; CONTROLLED STUDY; DRUG ELIMINATION; DRUG HALF LIFE; FEMALE; HUMAN; HUMAN TISSUE; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; RETROPERITONEAL HEMATOMA; STENT; THROMBOCYTE AGGREGATION INHIBITION;

EID: 0034809111     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000539-200110000-00015     Document Type: Article

References (10)

1. Abciximab and excessive bleeding in patients undergoing emergency cardiac operations
2. Emergency coronary bypass grafting for failed percutaneous coronary artery stenting: Increased costs and platelet transfusion requirement after the use of abciximab
3. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction
4. Pharmacokinetics and pharmacodynamics of glycoprotein IIb-IIIa inhibitors
5. The antiplatelet effects of ticlopidine and clopidogrel
6. Pharmacodynamics of chimeric glycoprotein IIb/IIIa integrin antiplatelet antibody Fab 7E3 in high-risk coronary angioplasty
7. Randomized trial of a glycoprotein IIb/IIIa platelet receptor blocker in refractory unstable angina
8. Pharmacodynamic profile of short-term abciximab treatment demonstrates prolonged platelet inhibition with gradual recovery from glycoprotein IIb/IIIa receptor blockade
9. Immediate and reversible platelet inhibition after intravenous administration of a peptide glycoprotein IIb/IIIa inhibitor during percutaneous coronary intervention
10. Heterogeneity of fibrinogen receptor expression on platelets activated in normal plasma with ADP: Analysis with flow cytometry